|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe. |
| 公司地址
| Zone Industrielle des Hauts-Sarts, Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040 |
| 電話號碼
| +1 866 259-5644 |
| 傳真號碼
| +32 42597875 |
| 公司網頁
| https://www.mdxhealth.com |
| 員工數量
| 364 |
| Mr. Michael K. McGarrity |
Director and Chief Executive Officer |
-- |
03/04/2026 |
| Mr. Ron Kalfus |
Chief Financial Officer and Principal Accounting Officer |
-- |
03/04/2026 |
| Mr. John Bellano |
Chief Commercial Officer |
-- |
03/04/2026 |
| Mr. Joseph Sollee |
Executive Vice President, Corporate Development and General Counsel |
-- |
03/04/2026 |
|
|
| Dr. Sanford J. Siegel, M.D. |
Independent Director |
03/04/2026 |
| Mr. Donnie Mccoy Hardison, Jr |
Independent Director |
03/04/2026 |
| Mr. Michael K. McGarrity |
Director and Chief Executive Officer |
03/04/2026 |
| Mr. Michael Holder |
Independent Director |
03/04/2026 |
| Ms. Hilde Windels |
Independent Director |
03/04/2026 |
| Mr. Koen Hoffman |
Non-Executive Chairperson of the Board |
03/04/2026 |
| Dr. Eric Bednarski |
Independent Director |
03/04/2026 |
|
|
|
|
